- Home
- KRG vs IRTC Comparison
KRG vs IRTC Comparison
Compare KRG & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRG
- IRTC
- Stock Information
- Founded
- KRG 1971
- IRTC 2006
- Country
- KRG United States
- IRTC United States
- Employees
- KRG N/A
- IRTC N/A
- Industry
- KRG Real Estate Investment Trusts
- IRTC Medical/Dental Instruments
- Sector
- KRG Real Estate
- IRTC Health Care
- Exchange
- KRG Nasdaq
- IRTC Nasdaq
- Market Cap
- KRG 5.0B
- IRTC 5.8B
- IPO Year
- KRG 2004
- IRTC 2016
- Fundamental
- Price
- KRG $22.25
- IRTC $185.29
- Analyst Decision
- KRG Buy
- IRTC Strong Buy
- Analyst Count
- KRG 10
- IRTC 13
- Target Price
- KRG $26.40
- IRTC $184.85
- AVG Volume (30 Days)
- KRG 1.8M
- IRTC 318.7K
- Earning Date
- KRG 10-29-2025
- IRTC 10-30-2025
- Dividend Yield
- KRG 4.85%
- IRTC N/A
- EPS Growth
- KRG N/A
- IRTC N/A
- EPS
- KRG 0.79
- IRTC N/A
- Revenue
- KRG $857,126,000.00
- IRTC $657,227,000.00
- Revenue This Year
- KRG $2.97
- IRTC $25.19
- Revenue Next Year
- KRG $1.74
- IRTC $17.01
- P/E Ratio
- KRG $28.32
- IRTC N/A
- Revenue Growth
- KRG 3.60
- IRTC 22.37
- 52 Week Low
- KRG $18.52
- IRTC $67.92
- 52 Week High
- KRG $28.24
- IRTC $190.86
- Technical
- Relative Strength Index (RSI)
- KRG 47.10
- IRTC 62.12
- Support Level
- KRG $21.75
- IRTC $179.93
- Resistance Level
- KRG $23.18
- IRTC $185.78
- Average True Range (ATR)
- KRG 0.45
- IRTC 5.85
- MACD
- KRG 0.04
- IRTC 0.25
- Stochastic Oscillator
- KRG 48.48
- IRTC 67.22
About KRG Kite Realty Group Trust
Kite Realty Group Trust specializes in owning, operating, acquiring, developing, and redeveloping high-quality open-air shopping centers and mixed-use assets. The company generates the majority of its revenue from contractual rents and reimbursement payments received from tenants.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.